We are live on
!
Find out more
CCM
Chiron Capital Management Portfolio holdings
AUM
$111M
This Fund
S&P 500
This Quarter
Est. Return
+0.95%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$159M
AUM Growth
+$20.1M
(+15%)
Cap. Flow
+$17.8M
Cap. Flow
% of AUM
11.21%
Top 10 Holdings %
Top 10 Hldgs %
53.56%
Holding
130
New
21
Increased
51
Reduced
40
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$10.4M |
| 2 |
AT&T
T
|
+$3.03M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$1.42M |
| 4 |
K
Kellanova
K
|
+$1.24M |
| 5 |
Skyworks Solutions
SWKS
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.43M |
| 2 |
Pfizer
PFE
|
+$1.38M |
| 3 |
Lockheed Martin
LMT
|
+$1.3M |
| 4 |
SLB Ltd
SLB
|
+$1.19M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$1.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.45% |
| 2 | Technology | 9.23% |
| 3 | Communication Services | 8.52% |
| 4 | Consumer Staples | 5.62% |
| 5 | Consumer Discretionary | 4.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Twilio
TWLO
$38.3B
| $260K | 0.16% |
+1,580
| New | +$288K |
|
102
Global Payments
GPN
$22.6B
| $246K | 0.16% |
1,800
-1,400
| -44% | -$196K |
|
|
FISV
103
Fiserv Inc
FISV
$27.4B
| $243K | 0.15% |
+2,400
| New | +$243K |
|
104
Canadian Natural Resources
CNQ
$95B
| $242K | 0.15% |
+7,964
| New | +$212K |
|
105
Flowers Foods
FLO
$1.56B
| $237K | 0.15% |
9,222
| – | – |
|
|
WCN
106
Waste Connections
WCN
$42.3B
| $237K | 0.15% |
1,700
| – | – |
|
107
FirstEnergy
FE
$27.5B
| $234K | 0.15% |
5,100
-1,300
| -20% | -$55K |
|
108
Chevron
CVX
$368B
| $224K | 0.14% |
1,378
-600
| -30% | -$86K |
|
109
ProShares Ultra Dow30
DDM
$544M
| $218K | 0.14% |
6,000
| – | – |
|
110
Bank of America
BAC
$440B
| $212K | 0.13% |
5,132
-60
| -1% | -$2.71K |
|
|
HBI
111
DELISTED
Hanesbrands
HBI
| $211K | 0.13% |
+14,200
| New | +$223K |
|
112
American International
AIG
$41.6B
| $207K | 0.13% |
3,300
-800
| -20% | -$48.1K |
|
113
Zoom
ZM
$30.5B
| $204K | 0.13% |
+1,741
| New | +$237K |
|
114
Phillips 66
PSX
$82B
| $202K | 0.13% |
+2,333
| New | +$196K |
|
115
Rocket Companies
RKT
$38.1B
| $177K | 0.11% |
+15,915
| New | +$197K |
|
116
Precigen
PGEN
$2.53B
| $151K | 0.1% |
71,547
+872
| +1% | +$2.12K |
|
|
MRCC
117
DELISTED
Monroe Capital Corp
MRCC
| $144K | 0.09% |
+13,360
| New | +$145K |
|
118
TG Therapeutics
TGTX
$7.54B
| $130K | 0.08% |
13,692
+1,920
| +16% | +$22.2K |
|
119
Hims & Hers Health
HIMS
$7.16B
| $113K | 0.07% |
21,200
+7,400
| +54% | +$36.6K |
|
120
Amplify Alternative Harvest ETF
MJ
$105M
| $108K | 0.07% |
+868
| New | +$104K |
|
121
Alaunos Therapeutics
TCRT
$4.88M
| $95K | 0.06% |
966
+171
| +22% | +$21.9K |
|
122
Wheels Up
UP
$199M
| $31K | 0.02% |
50
| – | – |
|
123
Sundial Growers
SNDL
$323M
| $8K | 0.01% |
1,173
| – | – |
|
124
Aurinia Pharmaceuticals
AUPH
$2.03B
| – | – |
-10,200
| Closed | -$233K |
|
125
British American Tobacco
BTI
$128B
| – | – |
-12,902
| Closed | -$483K |
|
Similar funds
EGP
WWMP
HCM
NIM
SPWM
JE
VP
IWP
Chiron Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Chiron Capital Management held 130 positions worth $159M, up 15% from $139M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Chiron Capital Management deployed $17.8M of net new capital in Q1 2022, opening 21 new positions and adding to 51 existing holdings. Its largest new stake was Skyworks Solutions: 7,326 shares worth $976K.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 44% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $6.43M trimmed.
- Chiron Capital Management's largest Q1 2022 buy was Skyworks Solutions: 7,326 shares worth $976K.
- Chiron Capital Management added most to State Street SPDR S&P Biotech ETF in Q1 2022, an estimated $10.4M increase.
- Chiron Capital Management's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $6.43M.
- Chiron Capital Management fully exited Activision Blizzard in Q1 2022, selling an estimated $1.02M.
- Chiron Capital Management's ten largest holdings make up 54% of its $159M portfolio in Q1 2022.
- Chiron Capital Management opened 21 new positions and closed 7 in Q1 2022.
- Chiron Capital Management's portfolio value rose 15% quarter-over-quarter to $159M.
Based on Chiron Capital Management's 13F filing for Q1 2022, filed 18 Apr 2022.